{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:31:14Z","timestamp":1759336274636,"version":"3.37.3"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004817","name":"Lund University Medical Faculty","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004817","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009780","name":"Region Sk\u00e5ne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001862","name":"the Swedish Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003173","name":"Crafoord Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Royal Physiographic Society of Lund"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.peptides.2016.03.012","type":"journal-article","created":{"date-parts":[[2016,3,26]],"date-time":"2016-03-26T07:45:35Z","timestamp":1458978335000},"page":"58-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Incretin hormone receptors are required for normal beta cell development and function in female mice"],"prefix":"10.1016","volume":"79","author":[{"given":"Bilal","family":"Omar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Ahlkvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchiro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Seino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Ahr\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2016.03.012_bib0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1677\/joe.0.1380159","article-title":"Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns","volume":"138","author":"Elliott","year":"1993","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.peptides.2016.03.012_bib0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02427280","article-title":"Reduced incretin effect in type 2 (non-insulin-dependent) diabetes","volume":"29","author":"Nauck","year":"1986","journal-title":"Diabetologia"},{"issue":"Suppl. 2","key":"10.1016\/j.peptides.2016.03.012_bib0015","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.2337\/dc11-s230","article-title":"Incretin effects on beta-cell function, replication, and mass: the human perspective","volume":"34","author":"Garber","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.peptides.2016.03.012_bib0020","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00125-002-0878-6","article-title":"Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients","volume":"45","author":"Vilsboll","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.peptides.2016.03.012_bib0025","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2016.03.012_bib0030","first-page":"952","article-title":"Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo","volume":"80","author":"Deacon","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.peptides.2016.03.012_bib0035","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1210\/endo.140.11.7143","article-title":"Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine","volume":"140","author":"Hansen","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2016.03.012_bib0040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1677\/JOE-07-0460","article-title":"The augmenting effect on insulin secretion by oral versus intravenous glucose is exaggerated by high-fat diet in mice","volume":"197","author":"Ahren","year":"2008","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.peptides.2016.03.012_bib0045","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1007\/s00125-011-2168-7","article-title":"Dipeptidyl peptidase-4 inhibition increases portal concentrations of intact glucagon-like peptide-1 (GLP-1) to a greater extent than peripheral concentrations in anaesthetised pigs","volume":"54","author":"Hjollund","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.peptides.2016.03.012_bib0050","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1210\/en.2011-0286","article-title":"Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice","volume":"152","author":"Waget","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2016.03.012_bib0055","doi-asserted-by":"crossref","first-page":"R544","DOI":"10.1152\/ajpregu.00123.2015","article-title":"The role of efferent cholinergic transmission for the insulinotropic and glucagonostatic effects of GLP-1","volume":"309","author":"Plamboeck","year":"2015","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.peptides.2016.03.012_bib0060","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1210\/endo.141.10.7720","article-title":"Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice","volume":"141","author":"Baggio","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2016.03.012_bib0065","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1210\/me.2004-0350","article-title":"Basal receptor activation by locally produced glucagon-like peptide-1 contributes to maintaining beta-cell function","volume":"19","author":"Masur","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.peptides.2016.03.012_bib0070","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4161\/isl.2.3.11396","article-title":"Intraislet production of GLP-1 by activation of prohormone convertase 1\/3 in pancreatic alpha-cells in mouse models of ss-cell regeneration","volume":"2","author":"Kilimnik","year":"2010","journal-title":"Islets"},{"key":"10.1016\/j.peptides.2016.03.012_bib0075","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1053\/j.gastro.2010.01.049","article-title":"Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion","volume":"138","author":"Fujita","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.peptides.2016.03.012_bib0080","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00125-011-2080-1","article-title":"Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus\u2014an adaptive response to hyperglycaemia","volume":"54","author":"Hansen","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.peptides.2016.03.012_bib0085","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nm.2513","article-title":"Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells","volume":"17","author":"Ellingsgaard","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.peptides.2016.03.012_bib0090","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1007\/s00125-012-2716-9","article-title":"A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets","volume":"55","author":"Marchetti","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.peptides.2016.03.012_bib0095","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-014-3299-4","article-title":"Dipeptidyl Peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from type 2 diabetic individuals","author":"Omar","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.peptides.2016.03.012_bib0100","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.cmet.2014.04.005","article-title":"The role of beta cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs","volume":"19","author":"Smith","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.peptides.2016.03.012_bib0105","doi-asserted-by":"crossref","first-page":"e96863","DOI":"10.1371\/journal.pone.0096863","article-title":"Incretin receptor null mice reveal key role of GLP-1 but not GIP in pancreatic beta cell adaptation to pregnancy","volume":"9","author":"Moffett","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2016.03.012_bib0110","doi-asserted-by":"crossref","first-page":"e101005","DOI":"10.1371\/journal.pone.0101005","article-title":"Role of endogenous GLP-1 and GIP in beta cell compensatory responses to insulin resistance and cellular stress","volume":"9","author":"Vasu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2016.03.012_bib0115","doi-asserted-by":"crossref","first-page":"E931","DOI":"10.1152\/ajpendo.00270.2002","article-title":"Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis","volume":"284","author":"Pamir","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.peptides.2016.03.012_bib0120","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.2337\/diabetes.47.7.1046","article-title":"Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor \u2212\/\u2212 mice","volume":"47","author":"Pederson","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2016.03.012_bib0125","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.2337\/diabetes.53.5.1326","article-title":"Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors","volume":"53","author":"Hansotia","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2016.03.012_bib0130","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1172\/JCI200420518","article-title":"Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors","volume":"113","author":"Preitner","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2016.03.012_bib0135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00198-014-2845-8","article-title":"Double incretin receptor knock-out (DIRKO) mice present with alterations of trabecular and cortical micromorphology and bone strength","volume":"26","author":"Mieczkowska","year":"2015","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.peptides.2016.03.012_bib0140","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2337\/db11-0995","article-title":"Distinct beta-cell defects in impaired fasting glucose and impaired glucose tolerance","volume":"61","author":"Kanat","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2016.03.012_bib0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.2040-1124.2010.00022.x","article-title":"GIP and GLP-1, the two incretin hormones: similarities and differences","volume":"1","author":"Seino","year":"2010","journal-title":"J. Diabetes Invest."},{"key":"10.1016\/j.peptides.2016.03.012_bib0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1172\/JCI25483","article-title":"Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure","volume":"117","author":"Hansotia","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2016.03.012_bib0155","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2337\/diabetes.55.02.06.db05-1051","article-title":"In vivo and in vitro glucose-induced biphasic insulin secretion in the mouse: pattern and role of cytoplasmic Ca2+ and amplification signals in beta-cells","volume":"55","author":"Henquin","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2016.03.012_bib0160","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00125-002-1028-x","article-title":"Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob\/ob) mice: evidence that GIP is the major physiological incretin","volume":"46","author":"Gault","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.peptides.2016.03.012_bib0165","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.2337\/diab.44.10.1202","article-title":"Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor","volume":"44","author":"Gremlich","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2016.03.012_bib0170","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1210\/en.2011-1385","article-title":"What if gut hormones aren\u2019t really hormones: DPP-4 inhibition and local action of GLP-1 in the gastrointestinal tract","volume":"152","author":"D'Alessio","year":"2011","journal-title":"Endocrinology"},{"issue":"Suppl. 2","key":"10.1016\/j.peptides.2016.03.012_bib0175","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.2337\/dcS13-2015","article-title":"GLP-1 effects on islets: hormonal, neuronal, or paracrine?","volume":"36","author":"Donath","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.peptides.2016.03.012_bib0180","doi-asserted-by":"crossref","DOI":"10.2337\/db14-0052","article-title":"Pleiotropic mechanisms for the glucose-lowering actions of DPP-4 inhibitors","volume":"63","author":"Omar","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2016.03.012_bib0185","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.2337\/diabetes.50.8.1720","article-title":"Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor","volume":"50","author":"Burcelin","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2016.03.012_bib0190","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1210\/endo.133.2.8102095","article-title":"Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line","volume":"133","author":"Gros","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2016.03.012_bib0195","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1523\/JNEUROSCI.2212-10.2011","article-title":"Hyperphagia and increased fat accumulation in two models of chronic CNS glucagon-like peptide-1 loss of function","volume":"31","author":"Barrera","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.peptides.2016.03.012_bib0200","doi-asserted-by":"crossref","first-page":"14843","DOI":"10.1073\/pnas.96.26.14843","article-title":"Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice","volume":"96","author":"Miyawaki","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.peptides.2016.03.012_bib0205","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nm727","article-title":"Inhibition of gastric inhibitory polypeptide signaling prevents obesity","volume":"8","author":"Miyawaki","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.peptides.2016.03.012_bib0210","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.2337\/db12-0976","article-title":"Link between GIP and osteopontin in adipose tissue and insulin resistance","volume":"62","author":"Ahlqvist","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2016.03.012_bib0215","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2337\/db07-0704","article-title":"Insulin action in the double incretin receptor knockout mouse","volume":"57","author":"Ayala","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2016.03.012_bib0220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N. Engl. J. Med."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019697811630047X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019697811630047X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T07:07:45Z","timestamp":1572937665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019697811630047X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":44,"alternative-id":["S019697811630047X"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2016.03.012","relation":{},"ISSN":["0196-9781"],"issn-type":[{"type":"print","value":"0196-9781"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incretin hormone receptors are required for normal beta cell development and function in female mice","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2016.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}